i bought this stock because the science behing their product seemed very promising and if the trials were to go well, then there would be a great upside to the stock price. Also, I then saw that the CEO was buying large quantities of the stock at about .25 per share which is a good sign and there was only buying and no selling by insiders. I was not aware of some of the negative aspects that are now surfacing such as profit taking by people who bought in at a low price from a private placement, a pumping effort that went bad, and now the fact that the clinical trials are approved only in Thailand and there is a hold by the FDA on any US trials. I bought 15000 shares at .26 and then another 15000 shares at .16 and am thinking of buying more if the price goes even lower. Does anyone have any feedback on where price may go from here and should more shares be bought to dollar average??
News 
Market Data 
Discover 
